期刊
CELL PROLIFERATION
卷 46, 期 3, 页码 254-262出版社
WILEY
DOI: 10.1111/cpr.12037
关键词
-
类别
资金
- National Natural Science Foundation of China [31070727, 30670889, 81273170]
- National Science Technology Major Special Project on Major New Drug Innovation [2010ZX09401]
- National Twelfth Five-Year Plan for Science and Technology Support [2012BAI37B03]
- Major State Basic Research Program-973 of China [2011CB503806]
Objectives Human CAP10-like protein 46 kDa (hCLP46), also known as Poglut1, has been shown to be an essential regulator of Notch signalling. hCLP46 is overexpressed in primary acute myelogenous leukaemia, T-acute lymphoblastic leukaemia samples and other leukaemia cell lines. However, effects of hCLP46 overexpression, up to now, have remained unknown. Materials and methods In this study, we established stable 293TRex cell lines inducibly overexpressing hCLP46, and knocked down hCLP6 with a specific small interfering RNA to explore function of the protein in Notch signalling and cell proliferation. Results hCLP46 overexpression enhanced Notch1 activation in 293Trex cells in a ligand-dependent manner, with increased Notch signalling enhancing Hes1 expression. We further verified that overexpression of hCLP46 inhibited proliferation of 293TRexs and was correlated with increases in cyclin dependent kinase inhibitors p21 and p27, whereas reduced hCLP46 expression moderately increased cell proliferation. In addition, p21 and p27 protein levels were higher when Notch signalling was activated by EDTA treatment. Conclusions Taken together, hCLP46 enhanced Notch activation and inhibited 293TRex cell proliferation through CDKI signalling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据